Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.076 AUD | +1.33% | -2.56% | +10.14% |
04-17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
04-17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+10.14% | 50.66M | |
-15.37% | 2.82B | |
+1.67% | 188M | |
-17.50% | 80.71M |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- Neurotech International Halts Trade Pending Release of Clinical Trial Data